Last reviewed · How we verify

NCT06641752: COCAP

Evaluation of CO Intoxication Rate, by CAPillary HbCO

Recruiting now Last updated 9 December 2025
What this trial tests

trial testing Blood drop sampling in Carbon Monoxide Intoxication in 120 participants. Currently enrolling.

Timeline
5 February 2025
Primary endpoint
5 February 2027
5 February 2027

Quick facts

Lead sponsorNantes University Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment120
Start date5 February 2025
Primary completion5 February 2027
Estimated completion5 February 2027
Sites2 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Nantes University Hospital

Who can join

18 and older, any sex, with Carbon Monoxide Intoxication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main goal of COCAP is to compare COHb (carboxyhemoglobin) levels measured from venous or arterial samples with those measured from capillary samples in patients suspected of Carbon Monoxide intoxication.Patient participation in the study will be limited to capillary sampling (approx. 5-15 minutes).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood drop sampling

Trials testing the same drug.

Other Nantes University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06641752.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing